Joint effects of inflammation and androgen metabolism on prostate cancer severity

International Journal of Cancer

Volumn 123, Issue 6, 2008, Pages 1385-1389

  Rebbeck, Timothy R ^a,b   Rennert, Hanna ^c   Walker, Amy H ^a   Panossian, Saarene ^a   Tran, Teo ^a   Walker, Kyle ^a   Spangler, Elaine ^a   Patacsil Coomes, Margerie ^a   Sachdeva, Rajeev ^d   Wein, Alan J ^a,b   Malkowicz, S Bruce ^a,b,d   Zeigler Johnson, Charnita ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene interactions; Hormone metabolism; Inflammation; Prostate cancer

Indexed keywords

ANDROGEN; CYTOCHROME; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; STEROID 5ALPHA REDUCTASE 2;

ADULT; ANAMNESIS; ANDROGEN METABOLISM; ARTICLE; CAUCASIAN; DISEASE SEVERITY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; GLEASON SCORE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE TUMOR; STATISTICAL SIGNIFICANCE;

ANDROGENS; CYTOCHROME P-450 CYP3A; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; MALE; PRECANCEROUS CONDITIONS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 49749102853     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23687     Document Type: Article

References (24)

1. De Marzo AM, DeWeese TL, Platz EA, Meeker AK, Nakayama M, Epstein JI, Isaacs WB, Nelson WG. Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J Cell Biochem 2004;91:459-77.
2. Guess HA. Benign prostatic hyperplasia and prostate cancer. Epidemiol Rev 2001;23:152-8.
3. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7:256-69.
4. van Leenders GJ, Gage WR, Hicks JL, van Balken B, Aalders TW, Schalken JA, De Marzo AM. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol 2003;162:1529-37.
5. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366-81.
6. Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004;13:635-8.
7. Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 2001;180:35-48.
8. Harris MT, Feldberg RS, Lau KM, Lazarus NH, Cochrane DE. Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate. Prostate 2000;44:19-25.
9. Asirvatham AJ, Schmidt M, Gao B, Chaudhary J. Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells. Endocrinology 2006;147:257-71.
10. Bettoun D, Scafonas A, Rutledge S, Hodor P, Chen O, Gambone C, Vogel R, McElwee-Witmer S, Bai C, Freedman L, Schmidt A. Interaction between the androgen receptor and RNase L mediates a crosstalk between the interferon and androgen signaling pathways. J Biol Chem 2005;280:38898-901.
11. Maggio M, Basaria S, Ceda GP, Ble A, Ling SM, Bandinelli S, Valenti G, Ferrucci L. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest 2005;28:116-9.
12. Ho E, Boileau TW, Bray TM. Dietary influences on endocrine-inflammatory interactions in prostate cancer development. Arch Biochem Biophys 2004;428:109-17.
13. Heinlein CA, Chang C. Androgen receptor (AR) coregulators: an overview. Endocr Rev 2002;23:175-200.
14. Davies P, Eaton CL. Regulation of prostate growth. J Endocrinol 1991;131:5-17.
15. McCormick DL, Rao KV, Dooley L, Steele VE, Lubet RA, Kelloff GJ, Bosland MC. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)- all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res 1998;58:3282-8.
16. Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, Isaacs WB, Nelson WG. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005;26:1170-81.
17. Zeigler-Johnson C, Friebel T, Walker AH, Wang Y, Spangler E, Panossian S, Patacsil M, Aplenc R, Wein AJ, Malkowicz SB, Rebbeck TR. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Res 2004;64: 8461-7.
18. Zeigler-Johnson CM, Walker AH, Mancke B, Spangler E, Jalloh M, McBride S, Deitz A, Malkowicz SB, Ofori-Adjei D, Gueye SM, Rebbeck TR. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. Hum Hered 2002;54: 13-21.
19. Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR. Association of susceptibility alleles in ELAC2/HPC2. RNASEL/HPC1, and MSR1 with prostate cancer severity in. European American and African American men. Cancer Epidemiol Biomarkers Prev 2005;14:949-57.
20. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
21. Shah U, Getzenberg R. Fingerprinting the diseased prostate: associations between BPH and prostate cancer. J Cell Biochem 2004;91: 161-9.
22. Cauffiez C, Lo-Guidice J, Chevalier D, Allorque D, Hamdan R, Lhermitte M, Lafitte J, Colombel J, Libersa C, Broly F. First report of a genetic polymorphims of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant. Hum Mutat 2004; 23:101.
23. Stone A, Ratnasinghe LD, Emerson GL, Modali R, Lehman T, Runnells G, Carroll A, Carter W, Barnhart S, Rasheed AA, Greene G, Johnson DE, et al. CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2005;14:1257-61.
24. Prins GS, Birch L, Tang WY, Ho SM. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 2007;23:374-82.